Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page adds Revision: v3.4.2, and removes a government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding lapse notice now appears on the page, stating that information may not be up to date. The site version was updated to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' label; minor metadata updates include capitalization changes for labels and removal of older entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange Detected- Page revision label updated from v3.3.3 to v3.3.4. This appears to be a versioning update and does not alter the study content on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section appears for the Philadelphia, PA site under Pennsylvania, replacing the old Pennsylvania Locations entry. The footer revision has been updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedPublications section wording updated to indicate entries are automatically filled from PubMed, and the page revision updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.